Your browser doesn't support javascript.
loading
SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.
Abdel-Fatah, Tarek M A; Broom, Reuben J; Lu, Jun; Moseley, Paul M; Huang, Baiqu; Li, Lili; Liu, Suling; Chen, Longxin; Ma, Runlin Z; Cao, Wenming; Wang, Xiaojia; Li, Yan; Perry, Jo K; Aleskandarany, Mohammed; Nolan, Christopher C; Rakha, Emad A; Lobie, Peter E; Chan, Stephen Y T; Ellis, Ian O; Hwang, Le-Ann; Lane, David P; Green, Andrew R; Liu, Dong-Xu.
Afiliación
  • Abdel-Fatah TMA; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Broom RJ; National Liver Institute, Menoufyia University, Menoufyia, Egypt.
  • Lu J; Auckland City Hospital, Auckland, New Zealand.
  • Moseley PM; The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.
  • Huang B; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Li L; The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China.
  • Liu S; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Chen L; Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Shanghai Medical College, Key Laboratory of Breast Cancer in Shanghai, Cancer Institutes, Fudan University, Shanghai, China.
  • Ma RZ; Laboratory of Molecular Biology, Zhengzhou Normal University, Zhengzhou, China.
  • Cao W; Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
  • Wang X; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Li Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Perry JK; The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
  • Aleskandarany M; Liggins Institute, University of Auckland, Auckland, New Zealand.
  • Nolan CC; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
  • Rakha EA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
  • Lobie PE; Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK.
  • Chan SYT; Tsinghua Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, Guangdong, China.
  • Ellis IO; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Hwang LA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
  • Lane DP; p53 Laboratory, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Green AR; p53 Laboratory, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Liu DX; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK. andrew.green@nottingham.ac.uk.
Br J Cancer ; 120(7): 728-745, 2019 04.
Article en En | MEDLINE | ID: mdl-30816325
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Oncogénicas / Carcinoma Ductal de Mama Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Oncogénicas / Carcinoma Ductal de Mama Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido